# Beta Cell Function in (Pre)Type 1 Diabetes

> **NCT01402037** · NA · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 100 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Glucose
- **DEVICE:** Continuous glucose monitoring

## Key facts

- **NCT ID:** NCT01402037
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2015-07
- **Final completion:** 2016-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-12-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402037, "Beta Cell Function in (Pre)Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01402037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*